Continuous Glucose Monitoring Education for Youth With Type 2 Diabetes
This study aims to teach young people with type 2 diabetes how to use continuous glucose monitoring and see if it helps keep their blood sugar levels within the target range over six months.
Continuous Glucose Monitoring Academy
+ Standard Education
Diabetes Mellitus+3
+ Diabetes Mellitus, Type 2
+ Endocrine System Diseases
Treatment Study
Summary
Study start date: June 23, 2025
Actual date on which the first participant was enrolled.This study focuses on helping young people who have Type 2 Diabetes (T2D) better manage their blood sugar levels. It compares a new educational program, called the Continuous Glucose Monitoring Academy, with the usual care that these individuals receive. The aim is to see if this new program can effectively teach young people how to use continuous glucose monitoring systems to manage their diabetes. Understanding how this program might improve blood sugar control is important because better management of diabetes can lead to improved health outcomes and quality of life for those affected. Participants in this trial will engage in four weeks of educational activities, which include using an online workbook, watching videos, and attending virtual sessions with a diabetes educator. These sessions will focus on strategies for managing blood sugar levels. Over the course of the study, participants will use their preferred Continuous Glucose Monitoring system, such as Dexcom or FreeStyle Libre, which are covered by their insurance. The study will look at various outcomes, including the ease of implementing this education program, its impact on blood sugar levels, and how it influences factors like diabetes-related stress and family involvement in diabetes care.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 8 to 21 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Children's Hospital Los Angeles
Los Angeles, United StatesOpen Children's Hospital Los Angeles in Google Maps